ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.

Jamal Mohammadian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.